Osaka Medical and Pharmaceutical University Repository
Not a member yet
    736 research outputs found

    救急集中治療医学領域におけるビッグデータ研究の潮流

    Get PDF
    departmental bulletin pape

    重症呼吸不全に対する治療戦略

    Get PDF
    departmental bulletin pape

    Chymase as a Novel Therapeutic Target in Acute Pancreatitis

    Get PDF
    大阪医科薬科大学博士(医学)2022doctoral thesi

    Mechanism of non-steroidal anti-androgen-induced liver injury: Reactive metabolites of flutamide and bicalutamide activate inflammasomes.

    Get PDF
    Flutamide is a non-steroidal anti-androgen agent, which is mainly used for the treatment of prostate cancer. Flutamide is known to cause severe adverse events, which includes idiosyncratic liver injury. However, details of the mechanism of these adverse reactions have not been elucidated. We investigated whether flutamide induces the release of damage-associated molecular patterns (DAMPs) that activate inflammasomes. We also tested bicalutamide, enzalutamide, apalutamide, and darolutamide for their ability to activate inflammasomes in differentiated THP-1 cells. The supernatant from the incubation of flutamide and bicalutamide with human hepatocarcinoma functional liver cell-4 (FLC-4) cells increased caspase-1 activity and production of IL-1ß by differentiated THP-1 cells. In the supernatant of FLC-4 cells with flutamide and bicalutamide, the heat shock protein (HSP) 40 or 60 was significantly increased. Addition of a carboxylesterase or a CYP inhibitor to the FLC-4 cells prevented release of HSPs from the FLC-4 cells. These results suggested that the reactive metabolites of flutamide and bicalutamide can cause the release of DAMPs from hepatocytes and activate inflammasomes. Inflammasome activation may be an important step in the activation of the immune system by flutamide or bicalutamide, which in some patients, can cause immune-related adverse events.journal articl

    世界最大のOMPU尿路上皮がん包括データセットによる腫瘍免疫微小環境の包括解析

    Get PDF
    departmental bulletin pape

    The flexion–extension gap is predictive of patient-reported outcome measures after cruciate-retaining total knee arthroplasty

    Get PDF
    大阪医科薬科大学博士(医学)2023doctoral thesi

    miR-515-5p suppresses trophoblast cell invasion and proliferation through XIAP regulation in preeclampsia

    Get PDF
    大阪医科薬科大学博士(医学)2022doctoral thesi

    Association between serum biomarkers and peripheral neuropathy in microscopic polyangiitis

    Get PDF
    大阪医科薬科大学博士(医学)2022doctoral thesi

    735

    full texts

    736

    metadata records
    Updated in last 30 days.
    Osaka Medical and Pharmaceutical University Repository
    Access Repository Dashboard
    Do you manage Open Research Online? Become a CORE Member to access insider analytics, issue reports and manage access to outputs from your repository in the CORE Repository Dashboard! 👇